Rolling Circle Amplification and Other Enrichment Strategies for eccDNA Libraries

Rolling circle amplification for eccDNA sits at the center of many library preparation workflows, yet most teams still ask the same question: do we really need eccDNA rolling circle amplification, and which enrichment strategy fits our study? This guide walks through eccDNA enrichment strategies, practical trade-offs, and how to connect those decisions to robust eccDNA sequencing projects and downstream eccDNA validation.

TL;DR – Do You Really Need Rolling Circle Amplification for eccDNA?

  • You do not always need rolling circle amplification for eccDNA libraries.
  • RCA boosts sensitivity for small, high-copy circles but can distort size and abundance.
  • Non-enriched eccDNA library preparation is better when you care about relative quantities.
  • Alternative eccDNA enrichment strategies (3SEP, ATAC-based, size selection) help when you target specific size ranges or ecDNA-like structures.
  • The best choice depends on your research goal, circle size range, and how quantitative the readout must be.

Use this article as a decision guide, then map your choice into a concrete Circle-seq eccDNA sequencing or eccDNA validation service plan.

Schematic comparing RCA enrichment, non-enriched libraries, and alternative eccDNA enrichment methods (3SEP, ATAC-based, size-selection), highlighting their relative trade-offs in sensitivity, quantitative accuracy, and circle size focus prior to library prep.

Why eccDNA Enrichment Strategies Matter Before Library Preparation

eccDNA enrichment is not just a technical add-on. It is a core study design decision that shapes which circles you detect, how confident you feel about quantitative changes, and how much sequencing depth you need.

Mechanism depicting the formation of extrachromosomal circular DNA (eccDNA/ecDNA) from linear chromosomes, and its contribution to gene copy number gain, altered regulation, and genome plasticity via amplification, reintegration, and interactions with R-loops/telomeric circles. (Ain Q. et al. (2020) International Journal of Molecular Sciences) Mechanistic overview of how extrachromosomal circular DNA (eccDNA and ecDNA) forms from linear chromosomes and contributes to gene copy number gains, altered gene regulation, and genome plasticity through amplification, reintegration, and interactions with R-loops and telomeric circles. (Ain Q. et al. (2020) International Journal of Molecular Sciences)

eccDNA enrichment strategies influence three things:

  • The minimum eccDNA copy number you can reliably see.
  • The size range of circles that dominate your data.
  • Whether read counts approximate biological abundance or reflect amplification bias.

For example, a discovery-style eccDNA sequencing project in cultured cells might tolerate some bias if the aim is to compile a long list of candidate eccDNAs. In contrast, a drug-response study that compares eccDNA levels between treatments needs a more conservative strategy, often with no RCA or only mild enrichment.

Typical project goals include:

  • Broad profiling of eccDNA landscapes across conditions or cell types.
  • Mechanistic studies focusing on eccDNA produced by specific genomic regions.
  • Oncology projects that care about larger circles and ecDNA-like structures.

Each of these goals benefits from a different combination of enrichment, eccDNA library preparation, and sequencing depth. This article translates high-level results from previous eccDNA overviews into concrete decisions you can apply at the bench or during project planning.

How Rolling Circle Amplification for eccDNA Works (and Where It Biases)

Rolling circle amplification for eccDNA is an isothermal amplification method that converts each circular DNA molecule into a long concatemeric product using a strand-displacing polymerase.

In a typical eccDNA RCA reaction:

  • A primer hybridizes to the circular DNA template.
  • A high-processivity polymerase, such as phi29, synthesizes DNA continuously.
  • The polymerase moves around the circle many times, generating a long linear concatemer.
  • Each concatemer contains many copies of the same eccDNA sequence, boosting its representation.

This mechanism creates strong, but selective, sensitivity. Several practical consequences follow:

  • Preference for small circles. Shorter circles are replicated more quickly per unit time, so they accumulate more concatemers.
  • Bias toward high-copy templates. Circles already present at higher copy number become heavily over-represented after RCA.
  • Dependence on primer access. Some eccDNA molecules are poorly primed due to sequence context or secondary structure, lowering their amplification efficiency.

A simplified eccDNA RCA workflow usually includes:

  1. Extraction of high-quality DNA and removal of linear fragments where possible.
  2. Denaturation and primer annealing to circular templates.
  3. Isothermal RCA reaction, often for several hours.
  4. Cleanup and fragmentation before eccDNA library preparation.

Example workflow for eccDNA sequencing utilizing exonuclease digestion of linear DNA, rolling circle amplification of circular templates, concatemer debranching, and long-read Nanopore sequencing to identify eccDNA-generating loci. (Merkulov P. et al. (2023) Plants) Example of an eccDNA sequencing workflow combining exonuclease-based removal of linear DNA, rolling circle amplification of circular templates, concatemer debranching, and long-read Nanopore sequencing to map eccDNA-producing loci. (Merkulov P. et al. (2023) Plants)

These steps are familiar to most wet-lab teams, yet the underlying biases are sometimes overlooked. RCA can be an excellent choice for qualitative detection of many small eccDNAs. However, it is less suitable when you need:

  • Reliable comparisons of eccDNA abundance across samples.
  • Accurate representation of large circles or ecDNA structures.
  • Close alignment between read counts and true biological copy number.

Understanding this bias does not mean avoiding RCA altogether. It means using eccDNA rolling circle amplification intentionally, in projects where its strengths outweigh its limitations.

Comparing RCA, No Enrichment, and Alternative eccDNA Enrichment Methods

When planning an eccDNA library, most teams choose between three broad strategies:

  • RCA-based enrichment: using eccDNA rolling circle amplification to boost circular templates.
  • Non-enriched libraries: preparing libraries directly from DNA with minimal or no selective steps.
  • Alternative enrichment methods: approaches such as 3SEP-like protocols, ATAC-style accessibility selection, or size-based methods.

A comparison table helps frame these options.

Strategy Sensitivity for low-abundance eccDNA Size bias Quantitative reliability Typical use cases
RCA-based eccDNA enrichment High for small, high-copy circles Strong preference for short circles Limited, often qualitative Discovery screens, atlas-style profiling in cell lines
Non-enriched eccDNA library preparation Moderate, depends on depth More balanced across sizes Better for relative comparisons Treatment comparisons, time-course studies, QC benchmarks
3SEP-like or exonuclease-based methods Good for circles vs linear DNA Depends on additional size selection Moderate, protocol-dependent Studies focusing on circular vs linear DNA distinction
ATAC-based eccDNA enrichment Enriches open chromatin-linked circles Favors eccDNA from accessible regions Context-specific, not global Regulatory or chromatin-linked eccDNA projects
Size-selection or ecDNA-oriented methods Designed for larger circles Enriches high-molecular-weight species Depends on input and workflow ecDNA and large eccDNA in tumors

A few key messages emerge from this comparison:

  • RCA offers strong sensitivity, but at the cost of quantitative distortion and size bias.
  • Non-enriched approaches generally require more sequencing but preserve relative abundance more faithfully.
  • Alternative enrichment strategies allow you to target specific biological questions, such as chromatin-linked eccDNA or tumor-associated ecDNA.

For many teams, the most practical approach is not to pick a single method forever, but to align the strategy with the current project phase. For example, an early screening study might use RCA to generate a catalog, followed by non-enriched or minimally enriched eccDNA sequencing service runs for shortlisted conditions.

Decision Framework – Choosing an eccDNA Enrichment Strategy for Your Study

You can choose an eccDNA enrichment strategy by answering three questions: what is my research goal, which eccDNA size range matters, and how quantitative must my data be?

Step 1: Define Your Primary Goal

Common goals include:

  • Discovery profiling: identify as many eccDNA loci as possible in a new system.
  • Comparative analysis: test how eccDNA patterns change across treatments, time points, or donors.
  • Mechanistic studies: focus on eccDNA derived from specific genes, repeats, or regulatory regions.
  • ecDNA-oriented oncology projects: emphasize large circles and high-copy oncogenic structures.

Step 2: Decide How Much You Need Quantitative Fidelity

Ask whether your conclusions depend on accurate relative abundance.

  • If you only need to know whether a locus produces eccDNA at all, RCA bias may be acceptable.
  • If your study relies on fold-change or subtle differences, non-enriched or gently enriched approaches are safer.

Step 3: Consider Expected Circle Size and Copy Number

Use prior data, literature, or pilot experiments:

  • Cell-line models often contain many small, high-copy eccDNAs.
  • Primary tissues and clinical samples may have lower abundance and a mix of sizes.
  • Tumor material can carry both small eccDNAs and ecDNA-like structures.

Step 4: Map to a Strategy

Some ready-to-use scenarios:

  • Genome-wide eccDNA discovery in cultured cells:
    • Recommended: RCA-based eccDNA enrichment plus deep sequencing.
    • Caveat: treat read counts as qualitative; follow up with targeted eccDNA validation.
  • Drug treatment comparison in the same cell line:
    • Recommended: non-enriched or minimally enriched eccDNA library preparation.
    • Reason: preserves relative abundance and supports statistical comparisons.
  • ecDNA and large-circle focus in tumor samples:
    • Recommended: size-selection or ecDNA-oriented enrichment, not standard RCA alone.
    • Combine with structural variant analysis in the downstream bioinformatics pipeline.

Documenting this logic in your protocol or eccDNA sequencing project brief helps align expectations between wet-lab, bioinformatics, and any external sequencing service provider.

Practical Wet-Lab Tips for eccDNA Rolling Circle Amplification and Enrichment

Beyond theory, small practical choices can dramatically change eccDNA library complexity and noise. The following suggestions reflect common issues seen across eccDNA projects and method optimization work.

Input DNA Quality and Amount

  • Use high-molecular-weight DNA whenever possible. Extensive shearing before enrichment reduces circle recovery.
  • Avoid repeated freeze–thaw cycles, which can damage delicate circles and affect RCA efficiency.
  • For RCA-based enrichment, teams often see stable performance when using at least low-microgram-scale input, though exact needs depend on sample type and downstream Circle-seq protocol.

If DNA quantity is limiting, consider whether a non-enriched strategy with careful library preparation and deeper sequencing could serve the biological question better than over-stretching an RCA reaction.

Enzyme, Primers, and Reaction Conditions

  • Use fresh or properly stored polymerase; activity loss directly reduces eccDNA detection.
  • Screen primer conditions on test samples before committing to a large batch. Poor priming typically manifests as low yield or over-representation of a few repetitive circles.
  • Keep reaction times within tested ranges. Extremely long RCA can increase non-specific products and raise background noise.

Many labs find it helpful to run a small optimization grid first, varying incubation time and enzyme amount while keeping DNA input constant. Recording these parameters in your eccDNA library preparation workflow notes makes troubleshooting easier later.

QC and Troubleshooting

Before proceeding to full library construction, simple checks can save time and sequencing cost:

  • Run a small aliquot on a gel or capillary system to confirm DNA amplification and size distribution.
  • If possible, perform a targeted qPCR against known eccDNA junctions in positive-control samples to confirm that enrichment is working as expected.
  • When yield is unexpectedly low, review DNA extraction, storage, and denaturation steps before changing polymerase conditions.

In practice, many problematic eccDNA RCA reactions trace back to upstream DNA handling rather than the RCA chemistry itself. Building a short QC checklist into your eccDNA enrichment SOP often pays off quickly.

Real-World Examples – How Enrichment Choices Shape eccDNA Results

Although each project is different, several recurring patterns appear when comparing RCA, non-enriched, and alternative eccDNA enrichment strategies. The following simplified scenarios illustrate how those choices affect outcomes.

Example 1: Discovery Screen in a Stable Cell Line

A team performed RCA-based eccDNA enrichment in a commonly used cancer cell line. The resulting eccDNA sequencing data revealed thousands of small circles, especially from repetitive regions. However, later non-enriched runs showed that larger circles, including ecDNA-like structures, were under-represented in the RCA dataset.

Size distributions and structural classes of plant retrotransposon-derived eccDNA molecules revealed by rolling circle amplification and Nanopore sequencing, demonstrating RCA-based enrichment bias towards specific size ranges and truncated forms. (Merkulov P. et al. (2023) Plants) Length distributions and structural classes of eccDNA molecules derived from plant retrotransposons after rolling circle amplification and Nanopore sequencing, illustrating how RCA-based enrichment can emphasize particular size ranges and truncated forms. (Merkulov P. et al. (2023) Plants)

Takeaway: RCA was excellent for building an initial eccDNA catalog, but the team needed complementary non-enriched libraries to characterize size distribution and structural diversity.

Example 2: Treatment Comparison with Modest Fold-Changes

Another group aimed to compare eccDNA output between treated and untreated samples. Early pilot work with RCA showed strong sample-to-sample variability that did not match other cellular readouts. Switching to a non-enriched eccDNA library preparation workflow reduced technical variance and produced differences that aligned better with biological expectations.

Takeaway: For modest fold-changes, quantitative fidelity outweighed the sensitivity gains from RCA.

Example 3: ecDNA-Oriented Tumor Project

In a tumor project, the investigators cared primarily about large, oncogene-containing circles and ecDNA-like structures. Standard RCA did not provide the desired resolution for these high-molecular-weight circles. Adding a dedicated size-selection step, combined with tailored bioinformatics that emphasized structural variants, improved detection of the relevant ecDNA subset.

Takeaway: When large circles are the focus, size-oriented enrichment and analysis matter more than global small-circle sensitivity.

These examples underscore a central theme: enrichment is a tool, not a goal. The best eccDNA enrichment strategy is the one that aligns with your biological question and downstream analysis plan.

FAQs – Common Questions About Rolling Circle Amplification for eccDNA

Q1: Do I always need RCA for eccDNA?

No, rolling circle amplification for eccDNA is not mandatory, and many projects work better without it.

You mainly need RCA when sensitivity is the priority and you can tolerate some bias in size and abundance. For relative quantification, treatment comparisons, or detailed ecDNA studies, non-enriched or alternative enrichment strategies often provide more trustworthy results.

Q2: Does RCA distort eccDNA copy-number and size distribution?

Yes, RCA can distort both apparent copy-number and size distribution in eccDNA libraries.

Small, high-copy circles are amplified more efficiently than large or low-copy circles, so they dominate the readout. This is acceptable for qualitative presence/absence questions but less suitable for precise quantification. When results must support statistical comparisons, consider limiting RCA or using non-enriched library preparation combined with higher sequencing depth.

Q3: Which enrichment strategy is best for ecDNA or large circles?

Standard RCA is usually not the optimal choice for ecDNA or very large eccDNA molecules.

For ecDNA-oriented studies, size-selection approaches and protocols designed to preserve high-molecular-weight DNA are more appropriate. These strategies can be combined with focused eccDNA sequencing services and structural variant analysis to capture ecDNA features. RCA may still be used in parallel for small eccDNA discovery, but it should not be the only enrichment method in such projects.

Q4: How much input DNA do I need for each enrichment option?

The required input depends on the strategy, but planning around microgram-scale DNA for RCA and high-nanogram to low-microgram amounts for non-enriched libraries is a practical starting point.

Low-input protocols exist, yet they often increase noise and reduce reproducibility. When sample input is limited, it is important to discuss realistic expectations and possible trade-offs with your internal bioinformatics team or an external eccDNA sequencing provider.

Q5: Can I combine different eccDNA enrichment strategies in one project?

Yes, combining strategies is often the most informative approach, especially in complex projects.

A discovery phase might use RCA-based eccDNA enrichment to map the space of possible circles. Later validation and quantification phases can switch to non-enriched libraries or targeted eccDNA validation services to confirm specific loci. Planning this combination from the start helps you design compatible library preparation workflows and sequencing plans.

From Enrichment Strategy to Sequencing Project – How We Can Help

Choosing between RCA, non-enriched, and alternative eccDNA enrichment strategies is easier when it is anchored to a concrete sequencing and analysis plan. A clear decision upfront helps avoid under-powered experiments, misinterpreted fold-changes, and costly re-runs.

If you are ready to move from planning to execution, consider:

When you reach out, share your sample type, expected eccDNA size range, and whether your primary goal is discovery, comparison, or ecDNA-focused analysis. With that context, it is possible to propose an eccDNA enrichment and library preparation strategy that matches both your scientific questions and practical constraints.

Related reading

References

  1. Ain, Q., Schmeer, C., Wengerodt, D., Witte, O.W. & Kretz, A. Extrachromosomal circular DNA: Current knowledge and implications for CNS aging and neurodegeneration. International Journal of Molecular Sciences 21(7), 2477 (2020).
  2. Merkulov, P., Egorova, E. & Kirov, I. Composition and structure of Arabidopsis thaliana extrachromosomal circular DNAs revealed by nanopore sequencing. Plants 12(11), 2178 (2023).
  3. Zaidi, S.S.-e.-A., Shakir, S., De Kort, H. et al. A comprehensive atlas of full-length Arabidopsis eccDNA populations identifies their genomic origins and epigenetic regulation. PLOS Biology 23(7), e3003275 (2025).
  4. Mehta, D., Cornet, L., Hirsch-Hoffmann, M. et al. Full-length sequencing of circular DNA viruses and extrachromosomal circular DNA using CIDER-Seq. Nature Protocols 15, 1673–1689 (2020).
  5. Zhao, Y., Yu, L., Zhang, S., Su, X. & Zhou, X. Extrachromosomal circular DNA: Current status and future prospects. eLife 11, e81412 (2022).
  6. Eugen-Olsen, R.A.B., Hariprakash, J.M., Oestergaard, V.H. & Regenberg, B. Molecular mechanisms of extrachromosomal circular DNA formation. Nucleic Acids Research 53(5), gkaf122 (2025).
For research purposes only, not intended for clinical diagnosis, treatment, or individual health assessments.


Related Services
Inquiry
For research purposes only, not intended for clinical diagnosis, treatment, or individual health assessments.

CD Genomics is transforming biomedical potential into precision insights through seamless sequencing and advanced bioinformatics.

Copyright © CD Genomics. All Rights Reserved.
Top